Regulus Therapeutics to Present at the H.C. Wainwright 22nd Annual Virtual Global Investment Conference
LA JOLLA, Calif., Sept. 11, 2020 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (“Regulus”), today announced that Jay Hagan, President and Chief Executive Officer of…
Comments Off on Regulus Therapeutics to Present at the H.C. Wainwright 22nd Annual Virtual Global Investment Conference